GUCY2C and colorectal cancer: Overall, in colorectal cancer, NKG2D [102], CD133 [82], GUCY2C (Guanylate Cyclase 2C) [40], and TAG-72 [103] are the most prominent target antigen to reaching the promising therapeutic goal.